Replies to post #263529 on Innovation Pharmaceuticals Inc (IPIX)

[cfoofme]

Think this could be a 15 Billion dollar deal also?

[zandant]

To add to your Allergan theory, george - "Allergan’s development programs in Gastroenterology are focused on advancing new treatments in ulcerative colitis, Crohn’s disease, NASH and diabetic gastroparesis." (From the Allergan website)


BEVERLY, MA – May 16, 2019 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has signed a non-binding term sheet with a global pharmaceutical company to develop and commercialize locally-administered Brilacidin (e.g., foam, enema, gel), on a worldwide basis, for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis.

The non-binding term sheet also includes a Right of First Refusal for rights to Brilacidin for the treatment of more extensive forms of Inflammatory Bowel Disease, such as Ulcerative Colitis and Crohn’s Disease, and a Right of First Negotiation for rights to Brilacidin in other Gastrointestinal (GI) indications."

UP/UPS are forms of ulcerative colitis.